According to IMARC Group’s latest report, titled “Breast Lesion Localization Methods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’ the global breast lesion localization methods market reached a value of US$ XX Billion in 2021. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2022-2027.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report
Request for a PDF sample of this report: https://www.imarcgroup.com/breast-lesion-localization-methods-market/requestsample
The increasing prevalence of breast cancer , along with the escalating requirement of lumpectomy and surgical biopsy procedures is one of the key factors primarily driving the market growth. In addition to this, the rising investment and fundings in the research and development (R&D) activities for enhancing biomedical, imaging, surgical, and breast lesion localization procedures are propelling the market growth. Apart from this, the growing demand for cosmetic surgeries, especially breast enhancement, and the numerous initiatives undertaken by the regulatory bodies of various countries for strengthening the healthcare infrastructure are positively stimulating the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global breast lesion localization methods market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, usage and end user.
Competitive Landscape:
- Argon Medical Devices Inc.
- Becton Dickinson and Company
- Cook Group Incorporated
- CP Medical Inc. (Theragenics Corporation)
- Endomagnetics Ltd.
- Hologic Inc.
- IsoAid LLC
- IZI Medical Products (Landauer Inc)
- Laurane Medical LLC
- Leica Biosystems Nussloch GmbH (Danaher Corporation)
- Merit Medical Systems Inc
- Sterylab S.r.l.
Breakup by Type:
- Wire Localization
- Radioisotope Localization
- Magnetic Tracers Localization
- Others
Breakup by Usage:
- Tumor Identification
- Sentinel Lymph Node Identification
- Lumpectomy
- Mastectomy
Breakup by End User:
- Hospitals
- Diagnostic Centres
- Oncology Clinics
- Ambulatory Surgical Centers
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/breast-lesion-localization-methods-market
We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800